Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TARO-ADAPALENE/BENZOYL PEROXIDE FORTE DIN 02505053

Status: Marketed
Holder: TARO PHARMACEUTICALS INC
Molecule: ADAPALENE
Available to quote

Health Canada record

Active ingredient(s)ADAPALENE 0.3 %; BENZOYL PEROXIDE 2.5 %
Dosage formGel
RouteTopical
SchedulePRESCRIPTION
ClassHuman
ATCD10AD53 ADAPALENE, COMBINATIONS
Original market date24-Jan-2022
Current status date24-Jan-2022
SourceHealth Canada DPD

Establishment licence of the holder

Taro Pharmaceuticals Inc — licence 100232, not currently licensed, last inspection rating C (2025-03-24).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ADAPALENE

DINProductCompanyFormStrengthStatus
02148749DIFFERINGALDERMA CANADA INC.GelADAPALENE 0.1 %Marketed
02231592DIFFERINGALDERMA CANADA INC.CreamADAPALENE 0.1 %Marketed
02376660DIFFERINGALDERMA CANADA INC.LotionADAPALENE 0.1 %Approved
02274000DIFFERIN XPGALDERMA CANADA INC.GelADAPALENE 0.3 %Marketed
02489007SANDOZ ADAPALENE / BENZOYL PEROXIDESANDOZ CANADA INCORPORATEDGelADAPALENE 0.1 %; BENZOYL PEROXIDE 2.5 %Marketed
02517205SANDOZ ADAPALENE / BENZOYL PEROXIDE FORTESANDOZ CANADA INCORPORATEDGelADAPALENE 0.3 %; BENZOYL PEROXIDE 2.5 %Marketed
02365871TACTUPUMPGALDERMA CANADA INC.GelADAPALENE 0.1 %; BENZOYL PEROXIDE 2.5 %Marketed
02446235TACTUPUMP FORTEGALDERMA CANADA INC.GelADAPALENE 0.3 %; BENZOYL PEROXIDE 2.5 %Marketed
02456923TARO-ADAPALENE/BENZOYL PEROXIDETARO PHARMACEUTICALS INCGelADAPALENE 0.1 %; BENZOYL PEROXIDE 2.5 %Marketed
02148757DIFFERINGALDERMA CANADA INC.LiquidADAPALENE 0.1 %Cancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
269472021-11-01Supplement to an Abbreviated New Drug Submission (SANDS)

International API supply for ADAPALENE

4 valid EDQM Certificates of Suitability from 4 holders. 10 active FDA Drug Master Files.

Request a quote for TARO-ADAPALENE/BENZOYL PEROXIDE FORTE

How to read a Canadian DIN record